亚太地区血浆分离市场预测至 2028 年 - COVID-19 影响和按产品(免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂和其他血浆产品)、应用(神经病学、免疫学、血液学、重症监护、肺病学和其他应用程序)和最终用户(医院和诊所、临床研究实验室和学术机构)

TIPRE00026269 | Pages: 134 | Medical Device | Dec 2021 | Type: Regional | Status: Published

市场介绍

亚太地区是血浆分离增长最快的市场,而中国、印度、日本、韩国、澳大利亚和亚太地区其他国家是该地区市场的主要贡献者。由于国际参与者对中国和印度的兴趣日益浓厚、中国等国家的政府支持以及不断进步的医疗基础设施,亚太地区在 2021 年全球血浆分离市场中占据了重要的市场份额。因此,该地区血浆分离市场参与者在预测期内具有巨大的增长潜力。

供应链干扰和对有效治疗新冠病毒疗法的巨大需求-19 使亚太地区的医疗保健研究行业处于至关重要的境地。已采取预防措施来控制这一流行病的蔓延。 COVID-19 大流行广泛影响了亚太地区的经济。印度、中国、日本和韩国等国家受到疫情的不利影响。社会经济受到严重影响,负通胀率上升,GDP负增长,地区失业率激增。中国、日本、新加坡和韩国等国家对临床试验的兴趣日益浓厚。西方国家的高成本也促使医疗事务外包流向亚太地区。为了扩大亚洲市场的销售,制药公司开始意识到药物、设备和体外诊断的新的和不断变化的监管环境。亚洲经常实施新的或改进的法规,包括 GMP 标准、药品价格控制和医疗器械监管体系的变化。作为当前标准的任何获取或改进的一部分,需要第三方的指导和建议。第三方外包服务提供商在支持亚太地区相关市场方面发挥着越来越重要的作用。然而,由于相关市场的控制程序、人们的意识、疫苗的供应以及政府对企业的支持政策,与大流行的初始阶段相比,市场已经稳定。                 

市场概况与动态

亚太地区血浆分离市场预计将从2021年的58.5465亿美元增长到2028年的94.3353亿美元;预计 2021 年至 2028 年复合年增长率为 7.1%。亚太地区其他地区包括新加坡、马来西亚、台湾、越南等东南亚国家和地区。一些国家的医疗和研究机构取得了显着增长,这反过来又导致了血浆分馏市场的增长。此外,糖尿病相关疾病病例的增加进一步推动了市场的发展。例如,根据2020年MDPI药剂学杂志发表的报告,DFU的患病率估计为5.5%。马来西亚被列为亚洲糖尿病病例最多的国家,约有 360 万患者。到 2025 年,预计约有 700 万成年人将患有糖尿病并可能发展为 DFU。这些因素将增加血浆分离市场的需求。      

主要细分市场

< p>亚太地区血浆分离市场按产品、应用、最终用户和国家/地区进行细分。亚太地区血浆分离市场根据产品分为免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂等。免疫球蛋白细分市场可能会在 2021 年占据最大的市场份额。亚太地区血浆分离市场根据应用分为神经病学、免疫学、血液学、重症监护、肺病学等。 2021 年,神经病学领域可能会占据最大的市场份额。亚太地区血浆分离市场根据最终用户分为医院和诊所、临床研究实验室、学术机构。 2021年,医院和诊所部门可能会占据最大的市场份额。按国家/地区划分,亚太地区血浆分离市场分为澳大利亚、中国、印度、日本、韩国和亚太地区其他地区。日本在 2021 年占据最大的市场份额。

主要来源和上市公司

准备本亚太地区血浆分离市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有 Bharat Serums and Vaccines Limited (BSV);生物制品实验室有限公司; CSL有限公司;格里福尔斯,SA; Kedrion SpA; Octapharma AG; PlasmaGen BioSciences Pvt.有限公司;和 SK Plasma。           

购买报告的理由

  • 了解亚太地区血浆分离市场格局并确定最有可能的细分市场保证丰厚的回报。
  • 了解亚太地区血浆分离市场不断变化的竞争格局,保持领先地位。
  • < span>通过识别最有可能销售前景的细分市场,有效规划亚太地区血浆分馏市场的并购和合作交易。
  • 帮助通过敏锐和全面的洞察力做出明智的业务决策分析亚太地区血浆分馏市场各个细分市场的市场表现。
  • 获取亚太地区 2021-2028 年各个细分市场的市场收入预测

亚太地区血浆分馏市场细分

亚太地区血浆分馏市场 - 按产品

  • 免疫球蛋白
    • 静脉注射免疫球蛋白(IVIG)
    • 皮下免疫球蛋白(SCIG)
  • 白蛋白
  • 浓缩凝血因子
  • 蛋白酶抑制剂
  • 其他

亚太地区血浆分馏市场 - 按应用

  • 神经病学
  • 免疫学
  • 血液学
  • 重症监护
  • 肺病学
  • 其他

亚太地区血浆分馏市场 - 按最终用户划分

  • 医院和诊所
  • 临床研究实验室
  • 学术机构

亚太地区血浆分馏市场 - 按国家/地区

  • 澳大利亚
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太地区其他地区

亚太地区血浆分馏市场 - 公司简介

  • Bharat Serums and Vaccines Limited ( BSV)
  • Bio Products Laboratory Ltd.
  • CSL Limited
  • Grifols,SA
  • Kedrion SpA
  • Octapharma AG
  • PlasmaGen 生物科学列兵。有限公司
  • SK Plasma

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Plasma Fractionation Market – By Product

1.3.2        APAC Plasma Fractionation Market – By Application

1.3.3        APAC Plasma Fractionation Market – By End User

1.3.4        APAC Plasma Fractionation Market – By Country

2.           APAC Plasma Fractionation Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Plasma Fractionation Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Plasma Fractionation Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Plasma Therapy is Becoming More Widely Used

5.1.2        Players' Active Involvement in Market Developments

5.2         Market Restraints

5.2.1        Options for Non-Plasma Substitutes

5.3         Market Opportunities

5.3.1        Growth Potential in Developing Countries

5.4         Future Trends

5.4.1        Novel Diseases Getting Treated with Use of Plasma Therapy

5.5         Impact Analysis

6.           Plasma Fractionation Market – APAC Analysis

6.1         APAC Plasma Fractionation Market Revenue Forecast and Analysis

7.           APAC Plasma Fractionation Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         APAC Plasma Fractionation Market, By Product 2021 & 2028 (%)

7.3         Immunoglobulin

7.3.1        Overview

7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.1          Intravenous Immunoglobulin (IVIG)

7.3.2.1.1          Overview

7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2          Subcutaneous Immunoglobulin (SCIG)

7.3.2.2.1          Overview

7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Albumin

7.4.1        Overview

7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Coagulation Factor Concentrates

7.5.1        Overview

7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Protease Inhibitors

7.6.1        Overview

7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Other Plasma Products

7.7.1        Overview

7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

8.           APAC Plasma Fractionation Market Revenue and Forecasts To 2028 – Application

8.1         Overview

8.2         APAC Plasma Fractionation Market Share by Application 2021 & 2028 (%)

8.3         Neurology

8.3.1        Overview

8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Immunology

8.4.1        Overview

8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Hematology

8.5.1        Overview

8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Critical Care

8.6.1        Overview

8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Pulmonology

8.7.1        Overview

8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Other Applications

8.8.1        Overview

8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.           APAC Plasma Fractionation Market Revenue and Forecasts To 2028 – End User

9.1         Overview

9.2         APAC Plasma Fractionation Market Share by End User 2021 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Clinical Research Laboratories

9.4.1        Overview

9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Academic Institutes

9.5.1        Overview

9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

10.        APAC Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     APAC: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

10.1.1.1       Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1       Overview

10.1.1.1.2       Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.3       Japan: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.1    Japan: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.1.4       Japan: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.5       Japan: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2       China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.2.1       Overview

10.1.1.2.2       China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.2.3       China: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.1    China: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.2.4       China: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.5       China: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3       India Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.3.1       Overview

10.1.1.3.2       India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.3.3       India: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.1    India: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.3.4       India: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.5       India: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4       South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.4.1       Overview

10.1.1.4.2       South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.4.3       South Korea: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.1    South Korea: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.4.4       South Korea: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.5       South Korea: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.5       Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.5.1       Overview

10.1.1.5.2       Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.5.3       Australia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3.1    Australia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.5.4       Australia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.5       Australia: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.6       Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3       Rest of APAC: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3.1    Rest of APAC: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.6.4       Rest of APAC: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4.1    Rest of APAC: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on APAC Plasma Fractionation Market

11.1      APAC: Impact Assessment of COVID-19 Pandemic

12.        Plasma Fractionation Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Followed by Major Market Players (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic developments

12.4.1     Overview

13.        Company Profiles

13.1      Octapharma AG

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Kedrion S.p.A

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      CSL Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Grifols, S.A.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bio Products Laboratory Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bharat Serums and Vaccines Limited (BSV)

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      SK Plasma

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      PlasmaGen BioSciences Pvt. Ltd.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Japan: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 2.             Japan: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 3.             Japan: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             Japan: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             China: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 6.             China: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 7.             China: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             China: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             India: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 10.          India: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 11.          India: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          India: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Korea: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 14.          South Korea: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 15.          South Korea: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          South Korea: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 18.          Australia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 19.          Australia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20.          Australia: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of APAC: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of APAC: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 23.          Rest of APAC: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of APAC: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic developments done by Companies

Table 27.          Glossary of Terms, APAC Plasma Fractionation Market

 


LIST OF FIGURES

Figure 1.           APAC Plasma Fractionation Market Segmentation

Figure 2.           APAC Plasma Fractionation Market Segmentation, By Country

Figure 3.           APAC Plasma Fractionation Market Overview

Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in APAC Plasma Fractionation Market

Figure 5.           Asia Pacific to Show Significant Growth During Forecast Period

Figure 6.           APAC PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to APAC Plasma Fractionation Market

Figure 8.           APAC Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9.           APAC Plasma Fractionation Market, by Product 2021 & 2028 (%)

Figure 10.        APAC Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        APAC Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        APAC Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        APAC Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        APAC Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        APAC Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 16.        APAC Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        APAC Plasma Fractionation Market Share by Application 2021 & 2028 (%)

Figure 18.        APAC Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19.        APAC Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20.        APAC Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21.        APAC Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 22.        APAC Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 23.        APAC Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 24.        APAC Plasma Fractionation Market Share by End User 2021 & 2028 (%)

Figure 25.        APAC Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 26.        APAC Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 27.        APAC Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 28.        APAC Plasma Fractionation Market Overview, by Country (2018)

Figure 29.        APAC: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

Figure 30.        Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 32.        India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 33.        South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 34.        Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 35.        Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        Impact of COVID-19 Pandemic in APAC Country Markets

Figure 37.        Growth Strategies Followed by Major Market Players (%)

  1. Bharat Serums and Vaccines Limited (BSV)
  2. Bio Products Laboratory Ltd.
  3. CSL Limited
  4. Grifols, S.A.
  5. Kedrion S.p.A
  6. Octapharma AG
  7. PlasmaGen BioSciences Pvt. Ltd.
  8. SK Plasma
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC plasma fractionation market   
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000